Abstract
Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.
Original language | English |
---|---|
Article number | 438 |
Journal | Genome biology |
Volume | 15 |
Issue number | 8 |
DOIs | |
State | Published - Aug 27 2014 |